Industry
Drug Manufacturers - Specialty & Generic
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer AG; Lilly; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co., Ltd; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Benzinga Newsdesk
June 20, 2024 | 12:25 pm
Portfolio Pulse from Benzinga Newsdesk
June 20, 2024 | 12:24 pm
Portfolio Pulse from Avi Kapoor
June 17, 2024 | 5:21 pm
Portfolio Pulse from Avi Kapoor
June 17, 2024 | 12:43 pm
Portfolio Pulse from Avi Kapoor
June 17, 2024 | 11:41 am
Portfolio Pulse from Benzinga Newsdesk
June 12, 2024 | 7:45 am
Portfolio Pulse from Benzinga Newsdesk
May 30, 2024 | 6:45 am
Portfolio Pulse from Benzinga Newsdesk
May 28, 2024 | 5:57 am
Portfolio Pulse from Benzinga Newsdesk
May 23, 2024 | 11:17 am
Portfolio Pulse from Benzinga Newsdesk
May 22, 2024 | 5:48 am
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.